Cadus Selected Fundamentals

Cadus Corporation -- USA Stock  

USD 1.56  0.01  0.65%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Cash Flow from Operations Analysis

Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investor or analyst to check on the quality of a company earnings.
Operating Cash Flow 
(2.85 M)

About Cash Flow from Operations

Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about company having enough liquid resources to meet current and long term debt obligations.
Compare to competition
In accordance with recently published financial statements Cadus Corporation has -2850000.0 in Cash Flow from Operations. This is 100.42% lower than that of the Healthcare sector, and 100.72% lower than that of Biotechnology industry, The Cash Flow from Operations for all stocks is 100.23% higher than the company.

Cadus Fundamental Drivers Relationships

Cadus Corporation is rated third overall in earnings per share category among related companies. It is rated below average in cash per share category among related companies .

Peer Comparison

Cadus Return On Equity Comparison
Cadus is currently under evaluation in return on equity category among related companies.

Did you try this?

Run Portfolio Diagnostics Now

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
Hide  View All  NextLaunch Portfolio Diagnostics